[1] |
TORRES C. Evolution and molecular epidemiology of polyomaviruses[J]. Infect Genet Evol, 2020, 79: 104150. DOI: 10.1016/j.meegid.2019.104150.
|
[2] |
ATKINSON AL, ATWOOD WJ. Fifty years of JC polyomavirus: a brief overview and remaining questions[J]. Viruses, 2020, 12(9): 969. DOI: 10.3390/v12090969.
|
[3] |
MAYBERRY CL, MAGINNIS MS. Taking the scenic route: polyomaviruses utilize multiple pathways to reach the same destination[J]. Viruses, 2020, 12(10): 1168. DOI: 10.3390/v12101168.
|
[4] |
MAZZONI E, PELLEGRINELLI E, MAZZIOTTA C, et al. Mother-to-child transmission of oncogenic polyomaviruses BKPyV, JCPyV and SV40[J]. J Infect, 2020, 80(5): 563-570. DOI: 10.1016/j.jinf.2020.02.006.
|
[5] |
FORNI D, CAGLIANI R, CLERICI M, et al. You will never walk alone: codispersal of JC polyomavirus with human populations[J]. Mol Biol Evol, 2020, 37(2): 442-454. DOI: 10.1093/molbev/msz227.
|
[6] |
BERGER JR, DANAHER RJ, DOBBINS J, et al. Dynamic expression of JC virus in urine and its relationship to serostatus[J]. Mult Scler Relat Disord, 2020, 41: 101972. DOI: 10.1016/j.msard.2020.101972.
|
[7] |
MAHLER C, SCHUMACHER AM, UNTERRAINER M, et al. TSPO PET imaging of natalizumab-associated progressive multifocal leukoencephalopathy[J]. Brain, 2021, DOI: 10.1093/brain/awab127[Epub ahead of print].
|
[8] |
SEPPÄLÄ HM, HELANTERÄ IT, LAINE PKS, et al. Archetype JC polyomavirus (JCPyV) prevails in a rare case of JCPyV nephropathy and in stable renal transplant recipients with JCPyV viruria[J]. J Infect Dis, 2017, 216(8): 981-989. DOI: 10.1093/infdis/jix435.
|
[9] |
AGUILAR J, CHANG DH, LIN M, et al. JC virus-associated nephropathy in a post-heart and -kidney transplantation patient[J]. Transpl Infect Dis, 2020, 22(3): e13288. DOI: 10.1111/tid.13288.
|
[10] |
WIEGLEY N, WALAVALKAR V, AUJLA H, et al. Clinicopathologic characteristics of JC virus nephropathy in kidney transplant recipients[J]. Transplantation, 2020, 105(5): 1069-1076. DOI: 10.1097/TP.0000000000003363.
|
[11] |
QUERIDO S, FERNANDES I, WEIGERT A, et al. High-grade urothelial carcinoma in a kidney transplant recipient after JC virus nephropathy: the first evidence of JC virus as a potential oncovirus in bladder cancer[J]. Am J Transplant, 2020, 20(4): 1188-1191. DOI: 10.1111/ajt.15663.
|
[12] |
ULERI E, PIU C, CAOCCI M, et al. Multiple signatures of the JC polyomavirus in paired normal and altered colorectal mucosa indicate a link with human colorectal cancer, but not with cancer progression[J]. Int J Mol Sci, 2019, 20(23): 5965. DOI: 10.3390/ijms20235965.
|
[13] |
REOMA LB, TRINDADE CJ, MONACO MC, et al. Fatal encephalopathy with wild-type JC virus and ruxolitinib therapy[J]. Ann Neurol, 2019, 86(6): 878-884. DOI: 10.1002/ana.25608.
|
[14] |
CIARDI MR, ZINGAROPOLI MA, IANNETTA M, et al. JCPyV NCCR analysis in PML patients with different risk factors: exploring common rearrangements as essential changes for neuropathogenesis[J]. Virol J, 2020, 17(1): 23. DOI: 10.1186/s12985-020-1295-5.
|
[15] |
SIGNORINI L, DOLCI M, FAVI E, et al. Viral genomic characterization and replication pattern of human polyomaviruses in kidney transplant recipients[J]. Viruses, 2020, 12(11): 1280. DOI: 10.3390/v12111280.
|
[16] |
LAUVER MD, LUKACHER AE. JCPyV VP1 mutations in progressive multifocalleukoencephalopathy: altering tropismor mediating immune evasion?[J]. Viruses, 2020, 12(10): 1156. DOI: 10.3390/v12101156.
|
[17] |
SOLIS M, GUFFROY A, LERSY F, et al. Inadequate immune humoral response against JC virus in progressive multifocal leukoencephalopathy non-survivors[J]. Viruses, 2020, 12(12): 1380. DOI: 10.3390/v12121380.
|
[18] |
SCHNEIDEWIND L, NEUMANN T, DRÄGER DL, et al. Leflunomide in the treatment of BK polyomavirus associated nephropathy in kidney transplanted patients -a systematic review[J]. Transplant Rev (Orlando), 2020, 34(4): 100565. DOI: 10.1016/j.trre.2020.100565.
|
[19] |
LAUTENSCHLAGER I, JAHNUKAINEN T, KARDAS P, et al. A case of primary JC polyomavirus infection-associated nephropathy[J]. Am J Transplant, 2014, 14(12): 2887-2892. DOI: 10.1111/ajt.12945.
|
[20] |
KANTARCI G, EREN Z, DEMIRAĞ A, et al. JC virus-associated nephropathy in a renal transplant recipient and comparative analysis of previous cases[J]. Transpl Infect Dis, 2011, 13(1): 89-92. DOI: 10.1111/j.1399-3062.2010.00567.x.
|
[21] |
WEN MC, WANG CL, WANG M, et al. Association of JC virus with tubulointerstitial nephritis in a renal allograft recipient[J]. J Med Virol, 2004, 72(4): 675-678. DOI: 10.1002/jmv.20037.
|
[22] |
FREEDMAN BI, KISTLER AL, SKEWES-COX P, et al. JC polyoma viruria associates with protection from chronic kidney disease independently from apolipoprotein L1 genotype in African Americans[J]. Nephrol Dial Transplant, 2018, 33(11): 1960-1967. DOI: 10.1093/ndt/gfx368.
|
[23] |
CHENG XS, BOHL DL, STORCH GA, et al. Inhibitory interactions between BK and JC virus among kidney transplant recipients[J]. J Am Soc Nephrol, 2011, 22(5): 825-831. DOI: 10.1681/ASN.2010080877.
|
[24] |
RAY U, CINQUE P, GEREVINI S, et al. JC polyomavirus mutants escape antibody-mediated neutralization[J]. Sci Transl Med, 2015, 7(306): 306ra151. DOI: 10.1126/scitranslmed.aab1720.
|
[25] |
BERZERO G, BASSO S, STOPPINI L, et al. Adoptive transfer of JC virus-specific T lymphocytes for the treatment of progressive multifocal leukoencephalopathy[J]. Ann Neurol, 2021, 89(4): 769-779. DOI: 10.1002/ana.26020.
|
[26] |
HUSSAIN I, TASNEEM F, GILANI US, et al. Human BK and JC polyomaviruses: molecular insights and prevalence in Asia[J]. Virus Res, 2020, 278: 197860. DOI: 10.1016/j.virusres.2020.197860.
|
[27] |
LIAW YC, CHEN CH, SHU KH, et al. Recombined sequences between the non-coding control regions of JC and BK viruses found in the urine of a renal transplantation patient[J]. Virus Genes, 2012, 45(3): 581-584. DOI: 10.1007/s11262-012-0815-9.
|